YouSaid · the spoken record

John Green

lines on the record: 35
first: 2025-05-15
most recent: 2025-05-15
sittings or episodes: 1
sources: podcast

Every line below is reproduced as it was said and linked to the record it came from. Nothing here is summarised or generated. Directory · Search · Corrections

“Well, first, we do spit into the ocean. You know, you got to do that sometimes. But secondly, I think the biggest thing that can happen right now, and we're starting to see partners in health do this in Lesotho and some other organizations try it as well, is we need to see blueprints for how this is actually going to happen. We need to see blueprints for dramatic reductions in tuberculosis, and that's not on the scale of billions of dollars. That's on the scale of millions of dollars. That's something that I can help out with, right? That's something that you can do a bake sale that helps out with. And so that's where I think that we really can see a difference at a smaller scale. If we can provide a blueprint for how we eliminate tuberculosis and say Lesotho, then that can apply to the entire world. It's just then that's when the big health funders have to come in and help us.”
2025-05-15 · Masters of Scale · Why we keep failing to eradicate this disease, with YouTuber John Green · IDENTIFIED FROM THE TRANSCRIPT
“He's doing great. I just talked to him this morning. I talked to him most days, and he's a junior at the University of Sierra Leone. He's just finishing his final exams now. I'm”
2025-05-15 · Masters of Scale · Why we keep failing to eradicate this disease, with YouTuber John Green · IDENTIFIED FROM THE TRANSCRIPT
“Oh, I would love to live to the day when tuberculosis is not a threat to public health, when tuberculosis is rare and readily cured. I would love to live to see a world where tuberculosis is rare and no longer a global health issue. I would like to see it become like typhoid, a disease that is rare, that doesn't kill a lot of people.”
2025-05-15 · Masters of Scale · Why we keep failing to eradicate this disease, with YouTuber John Green · IDENTIFIED FROM THE TRANSCRIPT
“Don't mean that it's the only one that matters. It means that that's where I'm focusing my energy and the hope and expectation that other people are focusing their energy on their big problems.”
2025-05-15 · Masters of Scale · Why we keep failing to eradicate this disease, with YouTuber John Green · IDENTIFIED FROM THE TRANSCRIPT
“Well, I am a very obsessive person, and I think one of the benefits of becoming obsessed with it is that we solve the problems we pay attention to. And if we feel like we're paying attention to a problem that not enough other people are paying attention to, that's really exciting in a lot of ways. It's also quite frustrating, right? It means that at dinner you're a weird company because you only want to talk about one thing and also many other people don't yet see how big a problem that one thing is. So that's both a benefit and a cost. I think the biggest cost is you can lose sight of the rest of the world, you know, like in becoming obsessed with tuberculosis. Am I still careful to make room for not just like malaria and HIV? Am I still careful to make room for climate change? Am I still careful to make room for the electrification of ovens or whatever? You know, there's so many problems in the world. You got to remember that there are many, many problems. And just because the one I'm obsessed with happens to be my obsession.”
2025-05-15 · Masters of Scale · Why we keep failing to eradicate this disease, with YouTuber John Green · IDENTIFIED FROM THE TRANSCRIPT
“I think that's so important to understand. I mean, the folks who have been laid off as a result of the USAID cuts, and I don't mean folks in the United States, I mean folks globally, they're being hired immediately and they're being hired by Chinese aid organizations because China still does understand the benefits of soft power.”
2025-05-15 · Masters of Scale · Why we keep failing to eradicate this disease, with YouTuber John Green · IDENTIFIED FROM THE TRANSCRIPT
“Experience United States foreign policy in other ways. And so I think this is the best money that we spend and the vast majority of it stays in the U.S. In fact, I've been critical of how much of it stays in the US. And so that's what I would say in response is we're talking about a rounding error in the federal budget. And the reason we talk about it a lot is because it's politically divisive. For many decades, I think the reason it was so strongly supported by partisanly was because it was such a good use of our resources, such a good way to build goodwill around the world.”
2025-05-15 · Masters of Scale · Why we keep failing to eradicate this disease, with YouTuber John Green · IDENTIFIED FROM THE TRANSCRIPT
“Well, first off, I'd just point out that the US has never prioritized TB efforts. The criticism of US aid for many years and other related organizations that are funded by the US government is that the vast majority of that money stays in the U.S. one way or another. It pays farmers. It pays contractors. It pays very little of that money ends up abroad. It pays drug manufacturers in the US. And so that's the first thing that I'd say is that it's never been neutral and it's always been oriented toward the interests of the United States. Second thing I'd say is that one of the most effective ways the U.S. has expressed its power over the last 60 years is through its generosity. Just to state the obvious, it's a very different experience to open up a package of life-saving nutrition bars that say a gift from the people of the United States than it is to”
2025-05-15 · Masters of Scale · Why we keep failing to eradicate this disease, with YouTuber John Green · IDENTIFIED FROM THE TRANSCRIPT
“Think we get there by polite but persistent pressure. And I think we get there through regulation, which I know is a word that many listeners of this podcast hate to hear. And I absolutely understand, look, I have to interact with worlds of regulation all the time. They can be extraordinarily unpleasant. I get that part of it. But if there is nobody pushing back, there is nobody saying, hey, when you accept $500 million of public money, there has to be some public benefit. If nobody's saying that, then we're in trouble.”
2025-05-15 · Masters of Scale · Why we keep failing to eradicate this disease, with YouTuber John Green · IDENTIFIED FROM THE TRANSCRIPT
“Really wants to make life better for people. They want to lower barriers to access. They want to improve healthcare outcomes. And yet we know that there's something wrong, right? We know there's something wrong because life expectancy is falling in the US. And we know that there's something wrong because we're seeing a flattening out of global health improvements. So we know there's a problem.”
2025-05-15 · Masters of Scale · Why we keep failing to eradicate this disease, with YouTuber John Green · IDENTIFIED FROM THE TRANSCRIPT
“The pressure that these folks are under is intense because they're under intense pressure for this quarter and next quarter and the quarter after that. And so what I hear is we're not in a position to do that because we have a responsibility to today's shareholders. My response to that would be the reason Johnson& Johnson is here is often because it hasn't done a good job of meeting the needs of the day but is instead focused on the long-term future and that's true for any corporation that's been around for over 100 years. They've shown a resiliency and ability to understand not just the current needs of the market but the future needs not just current system of values but a future system of values. And with J&J in particular I would point to their founders and the folks who made it possible for J&J to exist who were quite focused on social justice and making a better world. I think almost everyone who works at pharmaceutical companies or diagnostic companies or any corporation”
2025-05-15 · Masters of Scale · Why we keep failing to eradicate this disease, with YouTuber John Green · IDENTIFIED FROM THE TRANSCRIPT
“And today, the price of it has dropped by over 55% just in the last year. It's an incredible story. What I would do is I would go to my stakeholders, including my biggest shareholders, and I would say, look, we're going to do something slightly out of the box when it comes to disease in really poor countries. And what we're going to do is when we accept public funding,”
2025-05-15 · Masters of Scale · Why we keep failing to eradicate this disease, with YouTuber John Green · IDENTIFIED FROM THE TRANSCRIPT
“Johnson and Johnson had a patent on Badakhlin, this great TB drug. But when their patent expired, they filed secondary patents globally, including in India, to extend the life of that patent, which is a very common thing that pharmaceutical companies do. Some activists from India and South Africa came together to file a lawsuit in India to say, actually, this doesn't involve meaningful innovation and they shouldn't be allowed to file a secondary patent. And they succeeded. And so Johnson& Johnson wasn't able to file a secondary patent in India, which meant that generic competition for Badakuin could emerge in India. The problem was much of the rest of the world, they had succeeded in filing secondary patents. And so the fight had to continue to make sure that everybody could access Badakhalin. But eventually J&J abandoned all of their secondary patents on Badakhalin.”
2025-05-15 · Masters of Scale · Why we keep failing to eradicate this disease, with YouTuber John Green · IDENTIFIED FROM THE TRANSCRIPT
“Absolutely Well, it's really hard because J&J is working within a system, as you say, that has to prioritize shareholder returns. They have a fiduciary obligation to their shareholders to do so. And yet, they also have a pretty broad spectrum of goods and services that they provide to the market. And so it benefits Johnson and Johnson to live by their values. And to Johnson& Johnson's credit, this is something that they've done.”
2025-05-15 · Masters of Scale · Why we keep failing to eradicate this disease, with YouTuber John Green · IDENTIFIED FROM THE TRANSCRIPT
“Listeners, Bob, here, if you listen to rapid response on Masters of Scale, you may be missing half the show because every Friday we release a second rapid response exclusively in the rapid response feed. The guests and topics are just as compelling and timely from Ford CEO to NASA's administrator to the lessons from the Devilware's Prada. It takes about ten seconds to find just search rapid response wherever you listen to podcasts and hit follow to make sure you never miss an episode. I hope to see you there.”
2025-05-15 · Masters of Scale · Why we keep failing to eradicate this disease, with YouTuber John Green · IDENTIFIED FROM THE TRANSCRIPT
“Chest X-ray machines inside of them all throughout the country to places where there are high rates of TB. We offered people free chest x-rays, and then we gave them free treatment if they were positive for TB. And that's how we did it. And then so we search, we treat, and then we offer preventative care to those people's close contacts. So we offer one month of preventative antibiotics to their close contacts. So we just stopped that chain of transmission in its tracks. And we know that we've stopped it. Now to start, because of limited resources, we wouldn't be able to do that at scale around the globe, but we would be able to do pilot projects that can prove that you can basically reduce the burden of TB to zero even in large communities, like whether that's Karachi, Pakistan, or the entire nation of Lesotho.”
2025-05-15 · Masters of Scale · Why we keep failing to eradicate this disease, with YouTuber John Green · IDENTIFIED FROM THE TRANSCRIPT
“Okay, so there's two things that I would do. The World Health Organization has a fundamental problem when it comes to treating tuberculosis, which is limited resources. And the biggest way to fight that is with attention. And so I would go on a huge public relations campaign. I would try to make tuberculosis news again. I would try to make tuberculosis the center of our story again. And not just tuberculosis, but also malaria, other diseases of injustice, cholera, typhoid. Go back to a world where people are aware of these diseases. And then the second thing I would do is shift the priorities a little bit so that instead of just waiting until people are so sick that they come into the hospital, at which point their tuberculosis is often very hard to treat, I would do what's called case finding or massive search and treat program. And this is exactly how we eliminated tuberculosis or nearly eliminated tuberculosis in the United States. We sent out these mobile Winnebagos with”
2025-05-15 · Masters of Scale · Why we keep failing to eradicate this disease, with YouTuber John Green · IDENTIFIED FROM THE TRANSCRIPT
“Have to be honest with you, I think the first thing that I'm doing is retiring from my position as the head of the World Health Organization”
2025-05-15 · Masters of Scale · Why we keep failing to eradicate this disease, with YouTuber John Green · IDENTIFIED FROM THE TRANSCRIPT
“I'm ready. I'm excited. I mean, and at the same time, reluctant, Jeff, like anyone who's given a lot of power ought to be.”
2025-05-15 · Masters of Scale · Why we keep failing to eradicate this disease, with YouTuber John Green · IDENTIFIED FROM THE TRANSCRIPT
“And there's just a disconnect there. We have the same problem. I mean, this is not only a problem with tuberculosis, it's a problem with all bacterial infections. I remember I had orbital cellulitis in 2007, this infection between my eye and my brain was quite serious. I ended up spending 10 days in the hospital at NYU. And my infectious disease doctor came in on like the second or third day and said, if you've taken a white pill and I was like, yeah. And he said, did you take in a yellow pill? I was like, yeah. He's like, if you've taken a green pill, I was like, yeah. And he was like, have you taken a pill that cost $15,700 per pill? And I was like, no. And he was like, well, you're about to. And you can kind of do that in the rich world, right? Where you protect drugs by making them absurdly expensive. But in a country like Sierra Leone, that's a non-starter. No one will be able to access that medication.”
2025-05-15 · Masters of Scale · Why we keep failing to eradicate this disease, with YouTuber John Green · IDENTIFIED FROM THE TRANSCRIPT
“Unfortunately, it's not enough on its own because sort of by definition, antibiotics are a real challenge when it comes to incentives, right? Because from a market perspective, you want a drug that everyone takes all the time. And from an anti-”
2025-05-15 · Masters of Scale · Why we keep failing to eradicate this disease, with YouTuber John Green · IDENTIFIED FROM THE TRANSCRIPT
“Rich people still got tuberculosis in the first window. I think some kind of public private partnership like that is the way forward. That's the way to do it at scale. That's the way to do it to get the kind of better tools we need. Because it's true that tuberculosis is curable, but we could absolutely have better tools. I mean, the vast majority of people with TB are treated with the same drugs they would have been treated with in 1965. There are very few diseases for which that's the case, right? Like my brother's cancer was treated very differently in 2023 than it would have been in 1965”
2025-05-15 · Masters of Scale · Why we keep failing to eradicate this disease, with YouTuber John Green · IDENTIFIED FROM THE TRANSCRIPT
“So we've seen this a little bit actually because between 1945 and 1965, we developed eight classes of drugs to treat tuberculosis because there was a real market incentive to do so. And then between 1965 and 2012, we developed none. And that's the main reason we're in the mess that we're in right now, is those 50 years of failure.”
2025-05-15 · Masters of Scale · Why we keep failing to eradicate this disease, with YouTuber John Green · IDENTIFIED FROM THE TRANSCRIPT
“Well, I think there are ways that markets can work here, but there are also ways that markets fail here, right? Like the number one way that markets fail is that it's still from a human health perspective better to treat tuberculosis than it is to lengthen eyelashes, but from a market perspective, it's better to lengthen eyelashes than it is to treat tuberculosis. And that's a fundamental disconnect. And the only way to resolve that disconnect, in my opinion, is to have governments or other international authorities involved in reshaping the incentive structure so that it becomes profitable to treat tuberculosis more profitable to treat tuberculosis than it is to lengthen eyelashes.”
2025-05-15 · Masters of Scale · Why we keep failing to eradicate this disease, with YouTuber John Green · IDENTIFIED FROM THE TRANSCRIPT
“Well, I think the biggest solution I've seen to shrinking the empathy gap and look, I'm not going to say that it's perfect because I don't labor under the delusion that the social internet is good news, but is the social internet? People become proximal to all kinds of suffering that they weren't proximal to before, and that leads to action. It leads to collective action, leads to protest, leads to all kinds of social movements. Sometimes that stuff is messy and complicated, but it's at scale. And so that's why I've been trying to use my megaphone to get attention for tuberculosis is because I think that the social internet does work at scale. The problem is the people with the megaphones tend not to be people in impoverished communities. I mean, the poorest and most vulnerable among us are the people who are least likely to hear from. I think the solution at scale is some form of many to many conversation.”
2025-05-15 · Masters of Scale · Why we keep failing to eradicate this disease, with YouTuber John Green · IDENTIFIED FROM THE TRANSCRIPT
“Because they have very high rates of impoverishment. We know that when we cut the rates of impoverishment, even without medical intervention, we cut the rates of TBs. It's a resource problem on that level. There are also many other aspects to the problem, as I argue in the book, including a social dynamic that's really difficult to get past. We need to shrink the empathy gap between the rich world and the poor world. This is a huge problem. When we are proximal to suffering as a species, we are so generous. It's a shame that we need GoFundMe to be an addendum to the healthcare system in the United States. But think of how many GoFundMees have paid for everything from dog surgeries to life-saving organ donation operations. And yet when we're distant from suffering, when we can create distance between ourselves and suffering, we're so much less generous and we're much more likely, frankly, to be monstrous to think that people are not really people or to think that their lives are not as valuable as ours or there's nothing we can do or that ours.”
2025-05-15 · Masters of Scale · Why we keep failing to eradicate this disease, with YouTuber John Green · IDENTIFIED FROM THE TRANSCRIPT
“So absolutely, if we had enough money, we could do it, but it's a lot of money. It's like $25 billion a year, which I mean is a lot of money and not a lot of money, right? It's a lot of money in global health. It's not a lot of money necessarily in Silicon Valley sometimes. But it would take $25 billion a year according to the UN to really eradicate tuberculosis globally. The crisis is really everywhere. I mean, we have 10,000 cases of active TB in the United States every year. So there's no place that's immune to TB, but the epicenter of the crisis is India. Almost a third of the people who die of tuberculosis this year will die in India. There's also epicenters in Nigeria, in the Philippines, in Indonesia. Those are the biggest countries where there's really critical need. The highest rates we see of tuberculosis are in Lesotho, which is a small country in southern Africa where a lot of people work in mining. We know that any exposure to air pollutants makes tuberculosis worse. Also in countries like in West Africa like Sierra Leone, they have very high rates of tuberculosis.”
2025-05-15 · Masters of Scale · Why we keep failing to eradicate this disease, with YouTuber John Green · IDENTIFIED FROM THE TRANSCRIPT
“The main challenge is cost. I mean, Henry was told over and over again that it just wasn't cost effective to treat his particular tuberculosis too complicated, too drug-resistant. The real challenge for Henry was that he couldn't be treated with the first line antibiotics. They failed very early on. Then the second-line antibiotics failed. And then you end up with this incredibly toxic regimen of injectable drugs. And he endured that needlessly because if he'd had access to a molecular test, they would have known from the beginning that Henry was also resistant to those drugs. And so he needed a personalized, tailored treatment in order to survive. And it was only because Dr. Tefera and the Sierra Leonean Ministry of Health ultimately came to the conclusion that he deserved that and that it was worth the investment that Henry's here with us today.”
2025-05-15 · Masters of Scale · Why we keep failing to eradicate this disease, with YouTuber John Green · IDENTIFIED FROM THE TRANSCRIPT
“Antibiotics. That's why he looked relatively well, but they knew he wasn't responding to them well enough and that eventually his infection would roar back. And when it did, they just didn't have any tools to help him. And so it was really following Henry's story that, as you say, make this personal for me and help me understand that it's not just about a million deaths a year. It's the fact that each of those million people who are going to die are incalculably valuable have lives that are as rich and complex as my own and their griefs.”
2025-05-15 · Masters of Scale · Why we keep failing to eradicate this disease, with YouTuber John Green · IDENTIFIED FROM THE TRANSCRIPT
“Yeah, absolutely. So my wife and I visited Sierra Leone in 2019 with partners in health, the great nonprofit organization, to learn about maternal health there. And then on the last day of our trip, the folks we were traveling with asked if we could visit a tuberculosis hospital because they had some cases they wanted to consult on. We went to this TB hospital and the moment we arrived, I was just grabbed by this kid named Henry, which is also my son's name. And he seemed to be about the same age as my son. He looked to be about nine years old. That's how old my kid was at the time. And Henry just started walking me all around the hospital. He was like the mayor of that place. Everywhere we went, people were shaking his hand and rubbing his head and picking him up and giving him hugs. And he was just an incredibly charismatic person. And then we made our way back to the doctors and nurses who were meeting and they kind of lovingly shoed him away. And I said, whose kid is that? Is that one of your kids? And they said, no, he's a patient. And he's actually one of the patients we're really concerned about because it turned out Henry was responding to”
2025-05-15 · Masters of Scale · Why we keep failing to eradicate this disease, with YouTuber John Green · IDENTIFIED FROM THE TRANSCRIPT
“I very easily could have written a book about malaria or about HIV or about diabetes or about cancer. I mean, tuberculosis is by no means the only disease of injustice. It's just that for me it's the exemplary disease of injustice. It's an illness that has had a huge impact on our history. I mean, one out of every seven people or somewhere in that vicinity has died of tuberculosis of the people who've ever been born. And so it's a huge part of our history, but it's also a huge part of our present. And it really lays bare the truth of inequitable access to healthcare in our world, which is that we can come up with all the AI-fueled cures that we want. But if we don't get those cures to the people who most need them, we're just fundamentally failing ourselves.”
2025-05-15 · Masters of Scale · Why we keep failing to eradicate this disease, with YouTuber John Green · IDENTIFIED FROM THE TRANSCRIPT
“Well, first off, tuberculosis is not easy to cure. It's closer to curing cancer than it is to curing a sinus infection. It requires four to six months with the newest regimens of daily antibiotics. It's a disease that primarily affects the most impoverished people in the world. Anybody can get tuberculosis. It's airborne, but it is disproportionately affects the world's poorest people. And we've just done a terrible job of building systems that reflect the reality that everybody's life has equal meaning. And so we unfortunately do a terrible job of getting the cure to the people who need it most. There are all kinds of reasons why that breaks down from not developing good enough drugs to not get those drugs the last mile to the people who need them the most, but somewhere along the links in the chain, it keeps failing and failing and failing. And that's why we lose over a million people a year to TB.”
2025-05-15 · Masters of Scale · Why we keep failing to eradicate this disease, with YouTuber John Green · IDENTIFIED FROM THE TRANSCRIPT
“Well, one of the great challenges we face together is that discovering a cure doesn't mean that everyone gets access to that cure. And we've seen that most glaringly in the case of tuberculosis, which has been curable since the 1950s. But in the decades since it became curable, we've allowed over 150 million people to die of it. And I think the reason I ultimately wanted to write this book is because I'm so fascinated by the question of how that can happen.”
2025-05-15 · Masters of Scale · Why we keep failing to eradicate this disease, with YouTuber John Green · IDENTIFIED FROM THE TRANSCRIPT
“It would take $25 billion a year, according to the UN, to really eradicate tuberculosis globally, which, I mean, is a lot of money and not a lot of money, right? It's a lot of money in global health. It's not a lot of money necessarily in Silicon Valley.”
2025-05-15 · Masters of Scale · Why we keep failing to eradicate this disease, with YouTuber John Green · IDENTIFIED FROM THE TRANSCRIPT
“We solve the problems we pay attention to. And if we feel like we're paying attention to a problem that not enough other people are paying attention to, that's really exciting in a lot of ways. It's also quite frustrating, right? It means that at dinner you're a weird company because you only want to talk about one thing”
2025-05-15 · Masters of Scale · Why we keep failing to eradicate this disease, with YouTuber John Green · IDENTIFIED FROM THE TRANSCRIPT